Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2010 Feb 1;20(3):881-6. Epub 2010 Jan 4.

    Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design.

    Source

    Vitae Pharmaceuticals, 502 West Office Center Drive, Fort Washington, PA 19034, USA.

    Abstract

    Structure-guided drug design led to the identification of a class of spirocyclic ureas which potently inhibit human 11beta-HSD1 in vitro. Lead compound 10j was shown to be orally bioavailable in three species, distributed into adipose tissue in the mouse, and its (R) isomer 10j2 was efficacious in a primate pharmacodynamic model.

    Copyright (c) 2009 Elsevier Ltd. All rights reserved.

    PMID:
    20064717
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk